AnalystsGeorge SellersGeorge Sellers's Stock Forecasts
AnalystsGeorge Sellers
Analyst Ranking
Bottom 4%
#4684 out of 4870 analysts
Average Return
-28.01%
Win Rate
24%11 out of 46
Risk vs Reward
Poor
Good
George Sellers's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Glaukos CorpGKOS | +110.62% | $50.57 | $106.51 | 2023-05-04 - 2024-05-03 | Strong Buy |
Glaukos CorpGKOS | +94.94% | $41.28 | $80.47 | 2022-12-28 - 2023-12-27 | Strong Buy |
Glaukos CorpGKOS | +84.08% | $58.66 | $107.98 | 2023-05-08 - 2024-05-07 | Strong Buy |
Vericel CorpVCEL | +36.21% | $34.19 | $46.57 | 2023-09-21 - 2024-09-20 | Strong Buy |
Establishment Labs Holdings IncESTA | +34.28% | $34.10 | $45.79 | 2024-01-11 - 2025-01-10 | Strong Buy |
George Sellers Analyst Color
Get additional color on George Sellers's coverage of popular stocks
George Sellers's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cutera IncCUTRQ | 10 | Strong Buy | $5.00 | +5,054.64% | Maintains | 9 months ago |
Establishment Labs Holdings IncESTA | 7 | Strong Buy | $68.00 | +119.07% | Reiterates | 9 months ago |
Teleflex IncTFX | 9 | Strong Buy | $290.00 | +130.40% | Maintains | 9 months ago |
Vericel CorpVCEL | 2 | Strong Buy | $58.00 | +52.95% | Maintains | 9 months ago |
Transmedics Group IncTMDX | 2 | Strong Buy | $178.00 | +96.79% | Maintains | 9 months ago |
Anika Therapeutics IncANIK | 6 | Hold | $24.00 | +65.98% | Reiterates | a year ago |
Paragon 28 IncFNA | 3 | Strong Buy | $18.00 | N/A | Reiterates | a year ago |
Enovis CorpENOV | 1 | Strong Buy | $72.00 | N/A | Initiates Coverage On | a year ago |
Apyx Medical CorpAPYX | 2 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Treace Medical Concepts IncTMCI | 4 | Hold | $25.00 | N/A | Reiterates | 2 years ago |
Staar Surgical CoSTAA | 6 | Strong Buy | $57.00 | N/A | Reiterates | 2 years ago |
Glaukos CorpGKOS | 4 | Strong Buy | $71.00 | N/A | Reiterates | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.